
Adam C. Krupicka
Examiner (ID: 14823, Phone: (571)270-7086 , Office: P/1784 )
| Most Active Art Unit | 1784 |
| Art Unit(s) | 1784, 1794 |
| Total Applications | 934 |
| Issued Applications | 542 |
| Pending Applications | 87 |
| Abandoned Applications | 327 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12057068
[patent_doc_number] => 20170333412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'METHOD FOR TREATING LYMPHEDEMA'
[patent_app_type] => utility
[patent_app_number] => 15/520008
[patent_app_country] => US
[patent_app_date] => 2015-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 17994
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15520008
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/520008 | Method for treating lymphedema | Oct 19, 2015 | Issued |
Array
(
[id] => 11942006
[patent_doc_number] => 20170246158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'ATROPINE SULFATE RAPIDLY-DISINTEGRATING SUBLINGUAL TABLETS, METHODS FOR MANUFACTURE THEREOF, AND METHODS FOR USE THEREOF FOR TREATMENT OF ACUTE ORGANOPHOSPHATE TOXICITY'
[patent_app_type] => utility
[patent_app_number] => 15/516444
[patent_app_country] => US
[patent_app_date] => 2015-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9210
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15516444
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/516444 | ATROPINE SULFATE RAPIDLY-DISINTEGRATING SUBLINGUAL TABLETS, METHODS FOR MANUFACTURE THEREOF, AND METHODS FOR USE THEREOF FOR TREATMENT OF ACUTE ORGANOPHOSPHATE TOXICITY | Oct 1, 2015 | Pending |
Array
(
[id] => 10737183
[patent_doc_number] => 20160083333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-24
[patent_title] => 'FORMULATION COMPRISING ESTER QUATS BASED ON ISOPROPANOLAMINE AND TETRAHYDROXYPROPYL ETHYLENEDIAMINE'
[patent_app_type] => utility
[patent_app_number] => 14/861391
[patent_app_country] => US
[patent_app_date] => 2015-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11656
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14861391
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/861391 | Formulation comprising ester quats based on isopropanolamine and tetrahydroxypropyl ethylenediamine | Sep 21, 2015 | Issued |
Array
(
[id] => 11941997
[patent_doc_number] => 20170246148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'Methods and Compositions for Treating Psychotic Disorders'
[patent_app_type] => utility
[patent_app_number] => 15/510218
[patent_app_country] => US
[patent_app_date] => 2015-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 20602
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15510218
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/510218 | Methods and Compositions for Treating Psychotic Disorders | Sep 14, 2015 | Abandoned |
Array
(
[id] => 10467103
[patent_doc_number] => 20150352117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-10
[patent_title] => 'COMBINATION'
[patent_app_type] => utility
[patent_app_number] => 14/829689
[patent_app_country] => US
[patent_app_date] => 2015-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14985
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14829689
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/829689 | COMBINATION | Aug 18, 2015 | Abandoned |
Array
(
[id] => 11895105
[patent_doc_number] => 09765029
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-19
[patent_title] => 'Pyridine compounds as sodium channel blockers'
[patent_app_type] => utility
[patent_app_number] => 14/824319
[patent_app_country] => US
[patent_app_date] => 2015-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29790
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14824319
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/824319 | Pyridine compounds as sodium channel blockers | Aug 11, 2015 | Issued |
Array
(
[id] => 11755947
[patent_doc_number] => 20170202814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'AGENTS FOR THE TREATMENT OF RETROVIRAL INFECTIOUS DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/324576
[patent_app_country] => US
[patent_app_date] => 2015-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 14502
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15324576
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/324576 | Agents for the treatment of retroviral infectious diseases | Jul 9, 2015 | Issued |
Array
(
[id] => 11742818
[patent_doc_number] => 20170196891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'FATTY ACID BILE ACID CONJUGATES FOR TREATMENT OF LIPODYSTROPHY'
[patent_app_type] => utility
[patent_app_number] => 15/313640
[patent_app_country] => US
[patent_app_date] => 2015-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9498
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313640
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/313640 | FATTY ACID BILE ACID CONJUGATES FOR TREATMENT OF LIPODYSTROPHY | May 30, 2015 | Abandoned |
Array
(
[id] => 17350042
[patent_doc_number] => 11224660
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-18
[patent_title] => Stable cannabinoid formulations
[patent_app_type] => utility
[patent_app_number] => 14/724351
[patent_app_country] => US
[patent_app_date] => 2015-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13815
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14724351
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/724351 | Stable cannabinoid formulations | May 27, 2015 | Issued |
Array
(
[id] => 12098178
[patent_doc_number] => 09855260
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-02
[patent_title] => 'Quinolinone derivatives'
[patent_app_type] => utility
[patent_app_number] => 14/708424
[patent_app_country] => US
[patent_app_date] => 2015-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46761
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14708424
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/708424 | Quinolinone derivatives | May 10, 2015 | Issued |
Array
(
[id] => 10684437
[patent_doc_number] => 20160030583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-04
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE'
[patent_app_type] => utility
[patent_app_number] => 14/709342
[patent_app_country] => US
[patent_app_date] => 2015-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13914
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14709342
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/709342 | PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE | May 10, 2015 | Abandoned |
Array
(
[id] => 11964907
[patent_doc_number] => 20170269060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'Assays and Compounds to Treat Kidney Diseases'
[patent_app_type] => utility
[patent_app_number] => 15/310350
[patent_app_country] => US
[patent_app_date] => 2015-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 15883
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15310350
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/310350 | Assays and Compounds to Treat Kidney Diseases | May 7, 2015 | Abandoned |
Array
(
[id] => 11574616
[patent_doc_number] => 09629857
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-04-25
[patent_title] => 'Therapeutic uses of glutathione mimics'
[patent_app_type] => utility
[patent_app_number] => 14/694699
[patent_app_country] => US
[patent_app_date] => 2015-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 4690
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14694699
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/694699 | Therapeutic uses of glutathione mimics | Apr 22, 2015 | Issued |
Array
(
[id] => 11462717
[patent_doc_number] => 09579331
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-28
[patent_title] => 'Therapeutic uses of glutathione mimics'
[patent_app_type] => utility
[patent_app_number] => 14/694729
[patent_app_country] => US
[patent_app_date] => 2015-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 4689
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14694729
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/694729 | Therapeutic uses of glutathione mimics | Apr 22, 2015 | Issued |
Array
(
[id] => 10346106
[patent_doc_number] => 20150231111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'METHODS OF TREATING SKIN CONDITIONS USING CYCLOLIGNAN COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/691238
[patent_app_country] => US
[patent_app_date] => 2015-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8170
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14691238
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/691238 | Methods of treating skin conditions using cyclolignan compounds | Apr 19, 2015 | Issued |
Array
(
[id] => 10311502
[patent_doc_number] => 20150196504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-16
[patent_title] => 'CO-CRYSTALS OF TRAMADOL AND COXIBS'
[patent_app_type] => utility
[patent_app_number] => 14/665060
[patent_app_country] => US
[patent_app_date] => 2015-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10235
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14665060
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/665060 | CO-CRYSTALS OF TRAMADOL AND COXIBS | Mar 22, 2015 | Abandoned |
Array
(
[id] => 10311500
[patent_doc_number] => 20150196503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-16
[patent_title] => 'CO-CRYSTALS OF TRAMADOL AND COXIBS'
[patent_app_type] => utility
[patent_app_number] => 14/665055
[patent_app_country] => US
[patent_app_date] => 2015-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10236
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14665055
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/665055 | CO-CRYSTALS OF TRAMADOL AND COXIBS | Mar 22, 2015 | Abandoned |
Array
(
[id] => 10297463
[patent_doc_number] => 20150182462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-02
[patent_title] => 'Opioid-Containing Oral Pharmaceutical Compositions and Methods'
[patent_app_type] => utility
[patent_app_number] => 14/644263
[patent_app_country] => US
[patent_app_date] => 2015-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11910
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14644263
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/644263 | Opioid-Containing Oral Pharmaceutical Compositions and Methods | Mar 10, 2015 | Abandoned |
Array
(
[id] => 15631883
[patent_doc_number] => 10588909
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-17
[patent_title] => Modulators of HEC1 activity and methods therefor
[patent_app_type] => utility
[patent_app_number] => 14/645292
[patent_app_country] => US
[patent_app_date] => 2015-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 40689
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14645292
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/645292 | Modulators of HEC1 activity and methods therefor | Mar 10, 2015 | Issued |
Array
(
[id] => 10289128
[patent_doc_number] => 20150174126
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'Pharmaceutical combination'
[patent_app_type] => utility
[patent_app_number] => 14/639265
[patent_app_country] => US
[patent_app_date] => 2015-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8017
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14639265
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/639265 | Pharmaceutical combination | Mar 4, 2015 | Abandoned |